Sino Biopharmaceutical Ltd banner

Sino Biopharmaceutical Ltd
OTC:SBHMY

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
OTC:SBHMY
Watchlist
Price: 15.89 USD Market Closed
Market Cap: $14.9B

Relative Value

The Relative Value of one SBHMY stock under the Base Case scenario is hidden USD. Compared to the current market price of 15.89 USD, Sino Biopharmaceutical Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SBHMY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

SBHMY Competitors Multiples
Sino Biopharmaceutical Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
Sino Biopharmaceutical Ltd
OTC:SBHMY
116.8B USD 3.4 26.8 15.1 15.1
US
Eli Lilly and Co
NYSE:LLY
986.4B USD 15.1 47.7 32.2 34.2
US
Johnson & Johnson
NYSE:JNJ
586.1B USD 6.2 21.9 15.2 18.6
CH
Roche Holding AG
SIX:ROG
285.6B CHF 4.7 30.5 12.9 15
UK
AstraZeneca PLC
LSE:AZN
232.8B GBP 5.4 31.1 17.2 24.2
CH
Novartis AG
SIX:NOVN
239.7B CHF 5.5 22.1 13.6 17.5
US
Merck & Co Inc
NYSE:MRK
301.2B USD 4.6 16.5 10.3 12.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.4 9.8 11.5
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Pfizer Inc
NYSE:PFE
157.3B USD 2.5 20.2 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
123.4B USD 2.6 17.5 6.8 8.8
P/E Multiple
Earnings Growth PEG
HK
Sino Biopharmaceutical Ltd
OTC:SBHMY
Average P/E: 24.8
26.8
18%
1.5
US
Eli Lilly and Co
NYSE:LLY
47.7
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
21.9
7%
3.1
CH
Roche Holding AG
SIX:ROG
30.5
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.1
26%
1.2
CH
Novartis AG
SIX:NOVN
22.1
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.5
14%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
13.4
7%
1.9
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
US
Pfizer Inc
NYSE:PFE
20.2
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.5
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
Sino Biopharmaceutical Ltd
OTC:SBHMY
Average EV/EBITDA: 43.1
15.1
13%
1.2
US
Eli Lilly and Co
NYSE:LLY
32.2
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.2
2%
7.6
CH
Roche Holding AG
SIX:ROG
12.9
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.2
11%
1.6
CH
Novartis AG
SIX:NOVN
13.6
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.3
7%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.8
7%
1.4
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
6.8
-13%
N/A